U.S. Healthcare Services Stock News

Essent Group recently reported its latest quarter, with revenues of US$312.4 million flat year on year and in line with expectations, but earnings per share fell short of analyst estimates, an update that now sits in the rear-view mirror as of 16 March 2026. Despite management highlighting resilient operations and a durable business model supporting access to homeownership through private mortgage insurance and title services, the profit shortfall has raised questions about the company’s...

Wayfair recently launched its Wayfair Rewards program in Canada, offering members 5% back in rewards, free shipping, exclusive members-only pricing, and a members-only sale, for an annual fee of C$39. This move extends Wayfair’s loyalty ecosystem into a new geography, signaling a push to deepen repeat customer relationships and increase engagement across its Canadian platform. We’ll now explore how the Canadian launch of Wayfair Rewards, with its 5% back and free shipping benefits,...

Origin Bancorp stock after recent performance shifts Origin Bancorp (OBK) has drawn attention after a recent share price move, with the stock closing at $40.61 and showing mixed returns over the past week, month, and past three months. See our latest analysis for Origin Bancorp. Taking a step back, the recent share price pullback sits alongside a 30 day share price return decline of 7.16%, while the 1 year total shareholder return of 15.15% and 3 year total shareholder return of 27.42% point...

Why recent weak demand and higher leverage matter for Marriott Vacations Worldwide (VAC) Recent commentary around Marriott Vacations Worldwide (VAC) has focused on soft tour volumes, shrinking returns on capital, and a high net-debt-to-EBITDA ratio, all occurring against a backdrop of pressure on travel stocks from geopolitical tensions and higher oil prices. See our latest analysis for Marriott Vacations Worldwide. The recent leadership changes, including the appointment of a new Executive...

Greif (GEF) has just overhauled its debt profile with new secured credit facilities totaling US$1.3b, refinancing prior agreements and adding sustainability linked terms that can influence future borrowing costs and financial flexibility. See our latest analysis for Greif. Greif's new credit facilities arrive after a soft patch in the share price, with a 30 day share price return of a 12.24% decline and a year to date share price return of a 1.50% decline, even as the 1 year total shareholder...

Ameren Corporation recently reported fourth-quarter 2025 results that exceeded analyst expectations, with higher operating income driven by Ameren Missouri’s infrastructure investments and new electric service rates effective June 1, 2025, while also affirming its 2026 earnings guidance of US$5.25–US$5.45 per share. An interesting takeaway is how the Missouri segment’s performance highlights the earnings impact of regulated rate changes layered onto ongoing grid and infrastructure...

To help you decide whether Graphic Packaging Holding might offer value at today’s price, this article focuses squarely on what the current share price implies about the company. Recently, the stock has been weak, with returns of 9.7% over 7 days, 21.7% over 30 days, 35.8% year to date, and 61.8% over the last year, which may indicate that expectations and risk perceptions have shifted. These moves come as the company continues to attract attention in packaging, where investors often weigh...

Liberty Live Holdings event driven overview Liberty Live Holdings (LLYV) has come into focus after recent share price moves, with the stock at $92.04 following a 1 day return of a 2.85% decline and a 7 day return of an 8.44% decline. See our latest analysis for Liberty Live Holdings. While the recent 7 day share price return of an 8.44% decline and 1 day share price return of a 2.85% decline point to fading short term momentum, the 1 year total shareholder return of 39.36% and 90 day share...

Why Credit Acceptance Is on Investors’ Radar Without a single headline event driving attention, Credit Acceptance (CACC) is drawing interest as investors weigh its recent share performance against its current size, profitability profile, and niche in US auto financing. See our latest analysis for Credit Acceptance. The share price has stepped back to $447.79 after a 9.35% 1 day decline and a 10.72% 7 day share price return. The 1 year total shareholder return of an 8.02% decline contrasts...

Jefferies Financial Group (JEF) is under pressure after Western Alliance sued over a First Brands related loan and alleged missed payments of about $126.4 million, which is intensifying legal, credit and reputational questions for shareholders. See our latest analysis for Jefferies Financial Group. The recent lawsuit and investigations appear to have coincided with a sharp loss of momentum, with a 30 day share price return showing a decline of 32.32% and a year to date share price return...

Wondering if Enterprise Financial Services at around US$53.33 is offering good value or just fair value right now? This article breaks down what the current price may be implying. The stock has returned a loss of 2.3% over the past week and 12.3% over the past month, while the 3 year and 5 year returns sit at 22.2% and 20.1%. Recent coverage has focused on how regional banks are being assessed by investors, with attention on balance sheet strength, funding costs, and overall risk appetite...

First Bancorp (NasdaqGS:FBNC) announced the retirement of Michael G. Mayer from his roles as President and CEO of First Bank. Mayer is stepping back from day to day management but will continue to serve on the company’s Board of Directors. The change marks a leadership transition at the top of First Bank’s operating structure. First Bancorp, the holding company for First Bank, operates as a regional banking platform, offering lending, deposit, and related financial services. Leadership...

SEI Investments recently reported sustained strong revenue and earnings growth, with management crediting its core investment services and technology platforms for underpinning performance. A particularly interesting aspect of the update is that current annualized revenue and EPS growth are running ahead of the company’s own historical averages, suggesting its competitive moat may be strengthening. We’ll now explore how this improved earnings momentum, underpinned by SEI’s core technology...

Earlier this week, Ollie’s Bargain Outlet Holdings reported past fourth-quarter and full-year 2025 results showing higher sales of US$779.26 million and US$2.65 billion respectively, alongside increased net income and earnings per share, and issued 2026 guidance calling for net sales of about US$3.00 billion and operating income of roughly US$339 million to US$348 million. The company paired this performance with an acceleration plan that includes 75 new store openings in 2026, ongoing share...

Zimmer Biomet Holdings recently reported past fourth-quarter 2025 results with adjusted earnings per share of US$2.42 and net sales of US$2.24 billion, both ahead of analyst expectations and supported by growth across knees, hips, and S.E.T. products. The company’s guidance for 2026, calling for revenue growth of 2.5% to 4.5% and adjusted earnings per share of US$8.30 to US$8.45, gives investors a clearer view of how its portfolio and recent innovations might shape financial performance over...

Recent share performance and current business snapshot Affiliated Managers Group (AMG) has drawn attention after recent share moves, with the stock showing a 0.6% gain over the past day, alongside declines over the week and month. The company, an investment management firm with a market value of about US$7.3b, reports annual revenue of US$2,074.4m and net income of US$716.6m from its asset management operations. See our latest analysis for Affiliated Managers Group. Recent trading paints a...

In early March 2026, Genevant Sciences and Arbutus Biopharma reached a global settlement with Moderna over alleged unauthorized use of LNP delivery technology in its COVID-19 vaccines, with Moderna agreeing to pay US$950 million upfront in July 2026 and up to an additional US$1.30 billion depending on a future appellate ruling, while also receiving a global non-exclusive license for infectious disease applications. Around the same time, Moderna reported completion of a key Phase 1...

Jack Henry & Associates (JKHY) is back in focus after its Financial Crimes Defender platform was added to the Independent Community Bankers of America Preferred Service Provider program, highlighting its role in fraud prevention for community banks. See our latest analysis for Jack Henry & Associates. At a latest share price of $168.77, Jack Henry & Associates has seen a 7.71% 1 month share price return but a 10.06% 3 month share price decline. Its 5 year total shareholder return of 21.27%...

Interest in Polaris (PII) has picked up after its addition to the Russell 1000 ETF, along with plans to sell its Indian motorcycle brand to Carolwood and fresh coverage from Wells Fargo. See our latest analysis for Polaris. Despite the latest headlines, momentum in Polaris stock has cooled, with a 30-day share price return of 23.38% and a year to date share price return of 24.14%, even as the 1-year total shareholder return stands at 25.31%. Recent attention around its Russell 1000 inclusion,...

In recent days, Sunrun reported softer expectations for near-term earnings as analysts cut forecasts and voiced concern about slower solar origination and capacity deployment, even while revenue is still expected to grow. At the same time, Sunrun remains a major force in U.S. residential battery storage, controlling roughly half of 2025 installations and about 44% of national residential storage capacity, highlighting a tension between operational leadership and financial strain. Now we’ll...

Dianthus Therapeutics recently reported an early GO decision in its Phase 3 CAPTIVATE trial of claseprubart for CIDP, after achieving 20 confirmed responders ahead of the planned interim analysis and confirming a favorable safety profile through independent DSMB review. On the heels of these clinical results, the company completed a large follow-on public equity offering of common stock and pre-funded warrants, raising roughly US$719,000,000 to support ongoing trials, commercial readiness,...

What Recent Returns Say About BorgWarner BorgWarner (BWA) has drawn investor attention after a mixed run in its share price, with a recent month decline contrasting with gains over the past 3 months, year to date, and the past year. That backdrop, alongside annual revenue of about US$14.3b and net income of US$277 million, sets the stage for a closer look at how the auto technology supplier’s current valuation compares with its recent performance. See our latest analysis for BorgWarner. At...

In March 2026, Agios Pharmaceuticals announced that the Emirates Drug Establishment approved PYRUKYND (mitapivat) as the only authorized treatment in the UAE for adult patients with both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, expanding its reach in the Gulf region via its NewBridge Pharmaceuticals partnership. This approval deepens Agios’s footprint in rare hematologic diseases across the Gulf Cooperation Council, reinforcing the importance of...

Event context and recent share performance Sonic Automotive (SAH) has drawn investor attention after a period of mixed share performance, with the stock down about 1% over the past week and roughly 9% over the past 3 months. See our latest analysis for Sonic Automotive. At a share price of $59.89, Sonic Automotive’s recent 1 day and 90 day share price declines of 1.32% and 8.8% contrast with a 1 year total shareholder return of 4.01%. This suggests that short term momentum has cooled while...